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In the first year after orthotopic heart transplantation (OHT), acute cellular and/or humoral rejection is associated with coronary allograft vasculopathy (CAV) that can lead to graft failure. 1 CAV is still an unsolved issue. In spite of the increasingly successful treatment of rejection, 5-year survival after OHT for CAV detected within 3 years of transplant has improved only by 5% and remains lower than in patients without OHT (76 vs. 82%). 2 Coronary allograft vasculopathy affects both epicardial arteries and intramural small arteries and arterioles which constitute the microcirculation. Indeed, microvascular dysfunction often occurs in the absence of detectable epicardial lesions. In addition to the arterial district, CAV can also involve cardiac veins. 3, 4 A number of factors contribute to microvascular remodelling and dysfunction (Take home figure); they can be classified as alloantigen dependent or alloantigen independent, and the latter can be specific for OHT or a generic risk factors for type 1 microvascular dysfunction. 5 Immediately after OHT, HLA mismatch, cytomegalovirus mismatch between donor and recipient, donor age, recipient ischaemic cardiomyopathy, donor cause of death (brain injury), ischaemic time, and ischaemia/reperfusion insult are associated with development of CAV. Over time, other important factors contribute to aggravate CAV: multiple episodes of acute rejection, immunosuppressive therapy, and related hypertension. On the basis of endomyocardial biopsies, it has been postulated that endothelial lesions develop at first in the microcirculation. 3, 4 This hypothesis was substantiated by invasive measurement of the index of microvascular resistance 1 year after OHT.
Evidence of microvascular dysfunction 1 year after OHT was associated with mild depression of cardiac index, graft dysfunction, and worse prognosis, with a higher incidence of major cardiovascular adverse events at 5-year follow-up. 6 Cytokines released by T lymphocytes promote activation of alloreactive T cells, and activate macrophages and monocytes, which in turn stimulate the expression of adhesion molecules by endothelial cells. 7 The activated macrophages infiltrating the vessel wall accelerate smooth muscle cell proliferation and synthesis of extracellular matrix through cytokines and growth factors. 4, 7 The changes observed in small arteries were concentric intimal thickening, subendothelial accumulation of lymphocytes, and perivascular fibrosis, although arterioles <100 lm were not affected in the first year. 4 Due to allograft denervation, patients with CAV are often asymptomatic or complain of atypical symptoms. The ISHLT 2010 guidelines for heart transplant care suggest annual or biannual coronary angiography to assess the development of CAV (level of evidence A). Patients free of CAV at 3-5 years after OHT may undergo less frequent invasive evaluation. 8 The use of intravascular ultrasound (IVUS) and assessment of coronary flow reserve (CFR) have been classified as level of evidence C, and the functional assessment, when significant CAV is suspected, is mainly performed by means of single photon computed emission tomography (SPECT) that does provide information on small vessel disease. In this issue of the journal, Bravo et al. 9 report their findings in a cohort of 94 transplanted patients in whom myocardial blood flow (MBF) was quantified by positron emission tomography (PET created a PET-CAV severity score (on a scale of 0-3) that was modelled on the ISHLT criteria. Patients were followed for a median of 2.3 years for the occurrence of major adverse events including death, re-transplantation, acute coronary syndrome, and hospitalization for heart failure. Sensitivity, specificity, and positive and negative predictive values of semi-quantitative MPI for detecting moderate to severe CAV were 83, 82, 50, and 96%, respectively, and improved to 83, 93, 71, and 96%, respectively, when absolute stress MBF and LVEF were added to the analysis. There were 20 major adverse events during follow-up, and the annualized event rate was 5, 9, and 25% in patients with normal, mildly, and moderate to severely abnormal PET-CAV grading (P < 0.001), respectively. Thus, the main finding of this study is that quantification of absolute MBF improves the detection of CAV over conventional MPI, providing better patient stratification. There is no technique at present allowing the direct visualization of the coronary microcirculation in vivo. Coronary microcirculatory function can be indirectly assessed using techniques that enable measurement of MBF and CFR that, under normal circumstances, are strongly dependent on the functional integrity of the coronary microcirculation. The development and refinement of non-invasive cardiac imaging over the past two decades has provided new tools for the identification of pre-clinical disease. Studies using PET for the noninvasive quantification of regional MBF have demonstrated that coronary microvascular dysfunction (CMD) can be demonstrated in many clinical conditions in the absence of demonstrable stenoses on the large epicardial arteries. 10 In patients with coronary artery disease (CAD), MBF and CFR are often abnormal in territories subtended by non-stenotic epicardial arteries. 11 The additional prognostic value of attenuated CFR in patients with known or suspected CAD has been demonstrated in large cohorts of patients by different groups of investigators. Herzog et al. reported that a global CFR <2 allowed further stratification of cardiac risk in patients with abnormal perfusion at 10-year followup. 12 The incremental prognostic value of CFR was confirmed by
Murthy et al., 13 demonstrating that patients in the lowest tertile of CFR (<1.5) had a 5.6-fold increase in the risk of cardiac death compared with those in the highest tertile (>2). The added and independent predictive value of CFR over standard semi-quantitative parameters such as the Summed Stress Score has been reported in a sizeable population of 704 patients by Ziadi et al.
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The results of the study of Bravo et al. 9 demonstrate that absolute quantification of MBF with PET could be a valid alternative to ICA to detect CAV following OHT, obviating the need for invasive procedures and contrast medium. MBF quantification by PET is an integrated assessment of the functionality of both the epicardial coronary arteries and microcirculation, thus allowing information on the presence of CAV to be gathered at the microvascular level.
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